MGNX
MacroGenics Inc
3.60$
-6.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.1% | -15.1% | +18.6% | +925.4% | -84.0% | -25.6% | +68.6% | +227.5% | -43.4% | -49.6% | +58.0% | – | |
| – | +55,798.8% | -95.5% | +33.4% | +1,402.4% | -87.1% | +30.6% | +50.8% | +23.7% | -11.6% | -5.1% | +316.2% | – | |
| – | -456.8% | – | +14.1% | +756.5% | -82.1% | -50.8% | +89.8% | +420.3% | -50.5% | -67.5% | -244.9% | – | |
| – | +57.2% | -2.8% | +12.4% | -21.6% | -4.1% | -2.5% | +2.5% | -20.5% | +4.4% | +3.2% | +16.5% | – | |
| – | +1.2% | +17.1% | -1.9% | -2.2% | +97.2% | -61.5% | -13.2% | +6.5% | -6.8% | +5.1% | -18.6% | – | |
| – | -72.6% | +383.6% | +8.9% | -78.7% | +361.4% | -25.3% | -0.9% | -15.3% | +1.7% | +3.6% | +8.6% | – | |
| – | – | – | – | – | -197.5% | – | – | – | -164.9% | – | – | – | |
| – | – | -60.4% | -99.5% | -100.0% | – | +279.2% | +781.3% | +316.7% | +27.8% | +14.4% | -10.1% | – | |
| – | -362.5% | – | – | – | -125.7% | – | – | – | -188.8% | – | – | – | |
| – | – | -44.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -362.5% | – | – | – | -127.4% | – | – | – | -184.1% | – | – | – | |
| – | -326.5% | – | – | – | -121.4% | – | – | – | -140.8% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.